Why your Series A pitch is really a Fair Value defence in disguise

TL;DR. Sophisticated investors run a Fair Value model on you for years after the round closes — and the offer at term sheet reflects that model, not the pitch deck. Founders who build the evidence base before the room walk in defending a number, not optimising one. The 2025 IPEV Valuation Guidelines tightened the bar; the founders who notice will price their rounds at the top of the range.

There are two rooms a Series A founder needs to think about. The first is the one you've been preparing for: the partner meeting, the investment committee, the room where the pitch is delivered. The second is the one you'll never sit in: the Fund's quarterly Fair Value review, the room where your number is built, defended, and remarked for the next five to seven years.

The pitch wins the meeting. The Fair Value model wins the offer.

Most founders never see the second room. They optimise for the first — better deck, sharper narrative, tighter answers to the partner's questions — and wonder why the term sheet still arrives at a number that feels disconnected from the pitch they delivered. The disconnection is real. The questions a sophisticated investor asks at term sheet are downstream of the quarterly Fair Value process they will run on you for years. The deck doesn't decide the offer. The Fair Value model does.

Most founders walk into the room with one question: am I fundable, and for how much. The deck is built around the second half of that question. The offer is built around the first.

When an investor asks "what's your pre-money?" — the question every Series A founder rehearses an answer for — the answer they accept isn't the one founders rehearsed. It's the one their Valuer's Fair Value model produces. This is what changed in 2026, and what every founder raising a Series A in the next eighteen months needs to understand.

What changed in IPEV 2025

The 2025 IPEV Valuation Guidelines — the global standard PE and VC funds use to determine Fair Value of unlisted investments — became effective for reporting periods on or after 1 April 2026. The update was not cosmetic. It tightened five disciplines that funds now have to evidence at every measurement date:

The five tightenings shift the burden of evidence onto the Valuer — and through the Valuer, onto the Fund — to document, defend, and persist the Fair Value mark across the holding period. A Fund that takes a £15M investment in a Series A round at a £30M post-money cannot, under the 2025 guidelines, simply repeat the same number nine months later. They have to show how the calibration evidence has moved. They have to show what's known and knowable today that wasn't at entry. They have to reconcile maintainable EBITDA against the latest reviewed adjustments. And if the cap table contains hybrid instruments — SAFEs, convertible notes, advanced subscription agreements — they have to run scenario analysis or option pricing models on every conversion path.

That is a discipline tax on the Fund. Funds will not absorb it silently. They will push the evidence-building back onto founders during diligence, and through the offer.

The four lenses a Fund applies on day one

When a Fund's analyst opens your Series A diligence pack, they aren't really reading a pitch. They're populating four columns in their Fair Value model. Each column will be remarked quarterly for the life of the investment. Each column has a typical failure mode the founder didn't see coming.

1. Calibration evidence. Has the most recent funding round been documented with comparable transactions and noted multiples? Are the entry inputs traceable so deltas can be tracked at every measurement date? When the Fund marks you down 9 months later, does the founder have any defended response, or does it feel arbitrary? Without calibration, every quarterly mark feels arbitrary. With it, the offer at the next round has a defended path back to this one.

2. Maintainable earnings reconciliation. Has founders' EBITDA been reconciled to a Fund-style maintainable EBITDA? Are the non-recurring, discontinued, one-time, and pro-forma adjustments documented with evidence? IPEV Section 3.4 is unforgiving on this: two EBITDAs in a room with no shared evidence is a thirty-percent discount waiting to happen.

3. Cap-table hygiene. Does the cap table contain SAFEs, ASAs, convertible notes, or venture debt — and are the conversion scenarios documented? Under Section 5.20, three SAFEs at three valuation caps is six Fair Value scenarios, not one cap table. The "tidy cap table" the founder thinks they have is, to the Fund's analyst, a stack of unmodelled conversion paths.

4. Known-and-knowable inventory. Are the 12 intangible assets that drive valuation — Customer Capital, Brand & Reputation, Innovation Capital, Technology Capital, and the rest — documented with intangible asset evidence the Valuer can find? Under Section 2.5, evidence the Valuer can reasonably know about is in scope whether the founder surfaced it or not. Information that's known or knowable but un-surfaced is held against the company, not the analyst.

Key Takeaway. The pitch wins the meeting. The Fair Value model wins the offer. Most founders never see the second room.

These four columns, populated and reconciled, are the inputs to the Fund's Fair Value mark. They are also — and this is the founder's leverage point — the same evidence the Fund's analyst is going to model regardless. The founder who arrives at term sheet with the columns already populated isn't volunteering data; they're front-running an analysis the Fund was always going to do, and shaping it before the markdown logic kicks in.

Why "telling the story better" is the wrong fix

When the offer comes back forty percent below comps — and many do — the founder's instinct is to retell the story. Sharpen the deck. Add a slide on the moat. Walk through the cohort retention curve again. Reframe the TAM. The instinct is wrong, and the reason is structural.

The offer reflects the Fund's default Fair Value model, not their faith in your slides. Their analyst built the model from the four columns above. The model has produced a number. The partner has internalised the number. The number has been ratified by the investment committee. By the time the offer hits the founder's inbox, the model is doing the work — not the deck. Telling the story better doesn't move the model. The model has already moved.

What moves the model is changing the inputs available to the Valuer. That is a different action from the one most founders take. It requires building evidence before the room, not narrative inside it.

Note. The IVSC alignment statement embedded in the 2025 IPEV update reads simply: AI augments the Valuer; the Valuer remains accountable. For founders this matters: even if a Fund uses AI tools to triage diligence, the offer is still a Valuer's defended judgement — and judgement runs on inputs the founder controls.

The founder negotiating the optimised number is at war with the Valuer's model. The founder defending a number is supplying the model. One is a sales conversation. The other is doing the analyst's job before they do it.

What "Round-Ready" actually looks like

A founder who walks into a Series A defending a number, not optimising one, has spent the previous six months doing four things at once.

They have built a calibration file — the comparable transactions, the noted multiples, the entry-input documentation that lets a Valuer trace deltas across measurement dates. They have assembled the EBITDA bridge — the founder-style EBITDA reconciled to a maintainable EBITDA the Fund's analyst can defend, with each adjustment evidenced (board minutes, contracts, payroll documentation). They have cleaned the cap table — converted what they could, modelled what they couldn't, and prepared the scenario pack the Fund's analyst would otherwise build for them. And they have populated the 12-driver evidence inventory — every Customer Capital, Brand, Innovation, and Technology asset documented to a standard that earns the Opagio Hallmark for evidence quality.

The founder who arrives with this work done can answer the pre-money question with three short statements: here's what I've built, here's what it's worth, here's the evidence your Valuer will need to defend it for the next five years.

Six months sounds like a lot. It isn't. It's the same six months the founder is spending on deck refinement, advisor introductions, and partner-meeting prep — redirected towards the work the Fund was going to demand anyway.

Opagio Intangibles produces the evidence base that survives Fair Value scrutiny — so founders walk into institutional rounds defending a number, not optimising one.

The instrument that compresses this work is the Round Readiness Diagnostic. It scores the four lenses in eight minutes, names the gaps, and routes each gap to the part of the platform that closes it. There is no demo call. There is no sales conversation. The diagnostic is what tells the founder whether the second room has been prepared for, or only the first.

The founder who knows about the second room — and has built for it — does not walk in optimising. They walk in defending.

Further reading. This is the first piece in the IPEV Founder Series. Forthcoming pieces cover the four lenses in depth: cap-table hygiene under Section 5.20 (SAFEs, ASAs, and convertibles), calibration discipline, maintainable earnings reconciliation under Section 3.4, and known-and-knowable evidence under Section 2.5. For the underlying narrative-frame argument, see Round-Ready Academy Lesson 1: Why Your Valuation Is a Narrative, Not a Number. For the diligence-side perspective, see Series A Due Diligence: What Investors Look for in Intangibles. For the underlying valuation mechanics, see How do venture capital investors evaluate your pitch? and How do intangible assets interact with valuation multiples?.

Lead magnet. Download the Founder's Fair Value Checklist (PDF) — twelve questions a sophisticated investor will run on you within thirty days of close, structured against the four lenses.

Next step. Run the Round Readiness Diagnostic — eight minutes, four-axis score, named gaps with remediation paths.